Big Pharma is getting a massive upgrade. Persistent Systems and NVIDIA have

launched GenMolVS, a cutting-edge platform slashing drug discovery timelines from months to

mere days. By leveraging NVIDIA BioNeMo and advanced agentic AI, researchers can

now simulate molecular behavior digitally. This high-speed virtual screening eliminates costly lab

failures, accelerating the path to life-saving therapies with unprecedented, futuristic precision.